Elderly people are among those subjected to degrading treatment, with many left languishing on trolleys in urine-soaked bedding and no privacy, Age UK says.
This 'dearth' of information on symptoms and treatments is being filled by private companies who see menopausal women as a 'lucrative market', experts say.
Early indications suggest retatrutide is twice as effective as existing drugs at helping users slim but it is still in clinical trials and has not been approved for clinical use anywhere in the world.